Juvaris BioTherapeutics (United States)
- Research works
- 29 ▼ 100% vs 2013–17
- Citations
- 480 16.7 per fractional work
- Top-10% rate
- 5.7% record average 16.5%
- Open access
- 31% world 28%
Not ranked overall: Juvaris BioTherapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Juvaris BioTherapeutics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Innate Immunity, Antigen Presentation, Cancer Immunotherapy, Dendritic Cells, Immunity and Antibodies.
- Historical Thinking
- Citizenship Education
- Hepatocellular Carcinoma
- Breast Cancer
- Liver Disease
- Antiviral Therapy
- Chemotherapy
- Antibody Engineering
- Cytokine-Mediated Link
- Therapeutic Antibodies
- Immune Response
- Inflammation
- H1N1
- Genomics
- Antibodies
- Dendritic Cells
- Antigen Presentation
- Innate Immunity
- Epidemiology
- Pathogenesis
- Cancer Immunotherapy
- Immunity
- Vaccines
- Virus
- Influenza
- Pattern Recognition Receptors
- Monoclonal Antibodies
- Toll-like Receptors
- Innate Antiviral Responses
- Fc Receptors
- Angiogenesis
- Global Burden
- Vaccine
- HER2
- Chronic Hepatitis B
- Hepatitis B Virus
- Metastasis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 37 words, with their numbers
- Epidemiology6▲ 5.0×13 topics
- Innate Immunity4▲ 45×2 topics
- Pathogenesis4▲ 28×6 topics
- Antigen Presentation4▲ 154×2 topics
- Cancer Immunotherapy4▲ 106×2 topics
- Dendritic Cells4▲ 114×1 topic
- Immunity4▲ 39×1 topic
- Antibodies4▲ 141×2 topics
- Vaccines4▲ 176×2 topics
- Genomics3▲ 34×2 topics
- Virus3▲ 99×2 topics
- H1N13▲ 312×1 topic
- Influenza3▲ 236×1 topic
- Inflammation3▲ 4.2×6 topics
- Pattern Recognition Receptors3▲ 66×2 topics
- Immune Response2▲ 14×5 topics
- Monoclonal Antibodies2▲ 53×2 topics
- Therapeutic Antibodies2▲ 59×2 topics
- Toll-like Receptors2▲ 45×2 topics
- Cytokine-Mediated Link2▲ 102×1 topic
- Innate Antiviral Responses2▲ 102×1 topic
- Antibody Engineering2▲ 64×1 topic
- Fc Receptors2▲ 64×1 topic
- Chemotherapy2▲ 8.2×2 topics
- Angiogenesis2▲ 13×6 topics
- Antiviral Therapy2▲ 34×3 topics
- Global Burden1▲ 8.9×2 topics
- Liver Disease1▲ 35×2 topics
- Vaccine1▲ 12×5 topics
- Breast Cancer1▲ 17×1 topic
- HER21▲ 152×1 topic
- Hepatocellular Carcinoma1▲ 18×2 topics
- Chronic Hepatitis B1▲ 69×1 topic
- Citizenship Education1▲ 64×1 topic
- Hepatitis B Virus1▲ 69×1 topic
- Historical Thinking1▲ 142×1 topic
- Metastasis1▲ 10×2 topics
Which research topics does Juvaris BioTherapeutics (United States) publish most on?
By volume in 2022–2025: Wound Healing and Treatments, Monoclonal and Polyclonal Antibodies Research, CRISPR and Genetic Engineering and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Wound Healing and Treatments Rehabilitation 0 works
- 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 3 CRISPR and Genetic Engineering Molecular Biology 0 works
- 4 CAR-T cell therapy research Oncology 0 works
- 5 Corneal Surgery and Treatments Radiology, Nuclear Medicine and Imaging 0 works
- 6 Liver physiology and pathology Hepatology 0 works
- 7 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 0 works
- 8 Cardiac Fibrosis and Remodeling Cardiology and Cardiovascular Medicine 0 works
- 9 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Juvaris BioTherapeutics (United States)'s research output changed?
Output in 2018–2022 was 100% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Pleasanton
- Creative Research Enterprises (United States)
- STS International
- Innovation Research Center
- Blackberry (United States)
- Simpson Strong-Tie (United States)
- Thoratec Corporation (United States)
- Robust Chip (United States)
- 10X Genomics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.